Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES AJANTA PHARMA ALKEM LABORATORIES/
AJANTA PHARMA
 
P/E (TTM) x 32.8 23.7 138.4% View Chart
P/BV x 4.3 4.9 86.9% View Chart
Dividend Yield % 1.1 0.8 145.2%  

Financials

 ALKEM LABORATORIES   AJANTA PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
AJANTA PHARMA
Mar-22
ALKEM LABORATORIES/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,0681,614 252.0%   
Low Rs2,6711,089 245.4%   
Sales per share (Unadj.) Rs889.4391.1 227.4%  
Earnings per share (Unadj.) Rs140.583.4 168.4%  
Cash flow per share (Unadj.) Rs166.098.1 169.2%  
Dividends per share (Unadj.) Rs34.009.50 357.9%  
Avg Dividend yield %1.00.7 143.5%  
Book value per share (Unadj.) Rs722.4382.1 189.0%  
Shares outstanding (eoy) m119.5785.42 140.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.83.5 109.6%   
Avg P/E ratio x24.016.2 148.0%  
P/CF ratio (eoy) x20.313.8 147.4%  
Price / Book Value ratio x4.73.5 131.9%  
Dividend payout %24.211.4 212.5%   
Avg Mkt Cap Rs m402,868115,433 349.0%   
No. of employees `000NANA-   
Total wages/salary Rs m19,6276,458 303.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,34233,410 318.3%  
Other income Rs m1,6271,157 140.6%   
Total revenues Rs m107,96834,567 312.3%   
Gross profit Rs m20,3809,293 219.3%  
Depreciation Rs m3,0401,253 242.6%   
Interest Rs m524102 513.4%   
Profit before tax Rs m18,4439,095 202.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6401,968 83.3%   
Profit after tax Rs m16,8037,127 235.8%  
Gross profit margin %19.227.8 68.9%  
Effective tax rate %8.921.6 41.1%   
Net profit margin %15.821.3 74.1%  
BALANCE SHEET DATA
Current assets Rs m84,35424,548 343.6%   
Current liabilities Rs m48,0538,377 573.6%   
Net working cap to sales %34.148.4 70.5%  
Current ratio x1.82.9 59.9%  
Inventory Days Days4242 100.3%  
Debtors Days Days6511 580.6%  
Net fixed assets Rs m43,24519,259 224.5%   
Share capital Rs m239172 139.3%   
"Free" reserves Rs m86,13432,469 265.3%   
Net worth Rs m86,37332,640 264.6%   
Long term debt Rs m9416 572.0%   
Total assets Rs m127,59943,807 291.3%  
Interest coverage x36.290.2 40.2%   
Debt to equity ratio x00 216.1%  
Sales to assets ratio x0.80.8 109.3%   
Return on assets %13.616.5 82.3%  
Return on equity %19.521.8 89.1%  
Return on capital %21.928.2 77.9%  
Exports to sales %18.70-   
Imports to sales %00-   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,92418,678 106.7%   
Fx outflow Rs m3,9113,662 106.8%   
Net fx Rs m16,01315,016 106.6%   
CASH FLOW
From Operations Rs m11,1105,620 197.7%  
From Investments Rs m-14,351-741 1,936.7%  
From Financial Activity Rs m3,796-4,600 -82.5%  
Net Cashflow Rs m580279 207.7%  

Share Holding

Indian Promoters % 57.2 70.5 81.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.2 21.4 94.5%  
FIIs % 4.5 8.2 54.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.8 29.5 145.1%  
Shareholders   79,721 62,048 128.5%  
Pledged promoter(s) holding % 0.0 17.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs AJANTA PHARMA Share Price Performance

Period ALKEM LABORATORIES AJANTA PHARMA S&P BSE HEALTHCARE
1-Day 0.34% 1.29% 0.23%
1-Month -1.10% -4.86% 0.36%
1-Year -12.29% -9.96% -6.87%
3-Year CAGR 14.98% 23.29% 20.16%
5-Year CAGR 9.37% 6.17% 11.07%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.2% stake in the company. In case of AJANTA PHARMA the stake stands at 70.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

AJANTA PHARMA paid Rs 9.5, and its dividend payout ratio stood at 11.4%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.